Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

janssen-cilag international n.v.   - paliperidonpalmitat - schizofreni - psykoleptiske - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

Norveġja - Norveġiż - Statens legemiddelverk

h. lundbeck a/s - nortriptylinhydroklorid - tablett, filmdrasjert - 25 mg

Norveġja - Norveġiż - Statens legemiddelverk

h. lundbeck a/s - nortriptylinhydroklorid - tablett, filmdrasjert - 10 mg

Norveġja - Norveġiż - Statens legemiddelverk

h. lundbeck a/s - nortriptylinhydroklorid - tablett, filmdrasjert - 50 mg

Norveġja - Norveġiż - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 10 mg / 160 mg / 12.5 mg

Norveġja - Norveġiż - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 5 mg / 160 mg / 12.5 mg

Norveġja - Norveġiż - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 5 mg / 160 mg / 25 mg

Norveġja - Norveġiż - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 10 mg / 160 mg / 25 mg

Norveġja - Norveġiż - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 10 mg / 320 mg / 25 mg